Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Alpha2 adrenergic agonists for attention deficit hyperactivity disorder (ADHD)

Este protocolo ha sido retirado

ver el histórico de versiones

Información

DOI:
https://doi.org/10.1002/14651858.CD010016.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 20 enero 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Problemas de desarrollo, psicosociales y de aprendizaje

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Michael Venables

    Correspondencia a: Child and Adolescent Mental Health Services, Horsham, UK

    [email protected]

    [email protected]

  • Evangelia Ntzani

    Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece

  • Yingfen Hsia

    Department of Practice and Policy, School of Pharmacy, University College London, London, UK

  • Donna Gillies

    Western Sydney Local Health District ‐ Mental Health, Parramatta, Australia

Version history

Published

Title

Stage

Authors

Version

2017 Jan 20

Alpha2 adrenergic agonists for attention deficit hyperactivity disorder (ADHD)

Protocol

Michael Venables, Evangelia Ntzani, Yingfen Hsia, Donna Gillies

https://doi.org/10.1002/14651858.CD010016.pub2

2012 Aug 15

Alpha2 adrenergic agonists for attention deficit hyperactivity disorder (ADHD)

Protocol

Michael Venables, Evangelia Ntzani, Yingfen Hsia, Donna Gillies

https://doi.org/10.1002/14651858.CD010016